insights_auto
Outlook: 38.9% bullish·5.6% bearish
Go to analysischevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$758.27
arrow_upward
+1.03%(+7.76) 1D
$759.00
arrow_upward
+0.10% (+0.73)bedtimeAfter hours
Closed: Sep 30, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$749.84
High
$763.72
Low
$742.94
Mkt. cap
78.07B
Avg. vol.
711.00K
Volume
0.00
Dividend
0.50%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
18.75
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$749.84
High
$763.72
Low
$742.94
Mkt. cap
78.07B
Avg. vol.
711.00K
Volume
0.00
Dividend
0.50%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
18.75
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Investing.com Nigeria
·
7 minutes ago
Regeneron, Sanofi expand alliance with $1 billion upfront deal By Investing.com
Stock Titan
·
16 minutes ago
Four antibodies join a deal that pays Regeneron $1 billion upfront, with up to $7 billion more possible.
GuruFocus
·
5 hours ago
Regeneron (REGN) Grants One-Time Performance Awards to CEO and C
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com